Profile

Gavin has nearly thirty years of global experience across many sectors, with an emphasis on cross-border business and intellectual property issues. His experience includes corporate transactions, such as acquisitions, financings, licensing and divestitures and managing intellectual property holdings. Gavin has also advised clients on business issues with a special emphasis on regulatory, intellectual property and due diligence matters.

Gavin is a former U.S. patent attorney and a Canadian trademark agent. He has significant experience in life sciences, including pharmaceutical, biotechnology, and nutritional supplement matters. Prior to co-founding Magyar, Bogle, O’Hara, Gavin was General Counsel at Iovate, a mid-sized private Canadian company; Patent Counsel at Wyeth Pharmaceuticals in Cambridge MA; Senior Patent Attorney at Genetics Institute in Cambridge MA; and a patent attorney at a major New York IP firm. Gavin also held a clerkship at the Tax Court of Canada.

As of March 1, 2024, Gavin works on trademark matters and intellectual property strategy through Bogle Strategic IP Services, and is no longer engaged in the private practice of law and does not provide legal advice to clients.

Gavin has been a frequent speaker at international and domestic conferences on Canadian-American cross-border issues as well as issues pertaining to intellectual property due diligence and acquisitions.

Teaching and Lecturing Experience

Innovation and Intellectual Property. Pediatrics 2040: Trends and Innovation for the next 40 years. Dana Point, CA, January 7–8, 2016.

“What’s left of method patents?”, IP Counsel Committee Meeting, 2010

“Budgeting for Good Client Relationships”, American Intellectual Property Law Association Mid Winter Institute, 2008

“Due Diligence: Patent Landscape Review and Freedom to Operate Analysis”, Federated Press, 2011

“What’s Left of Method Patents?”, Intellectual Property Counsels Committee Conference, Biotechnology Innovation Organization, 2010

“Patent Analysis as a Tool for Competitive Intelligence”, Federated Press, 2010

“Patents as Competitive Strategy”, Federated Press, 2009

“Budgeting for Good Client Relationships”, Mid-Winter Institute, American Intellectual Property Law Association, 2008

“Licensing Your Way Out of Trouble”, Freedom to Operate Conference, American Conference Institute, 2006

“Successfully Preparing for and Managing Litigation”, National Forum on Preventing and Defending Pharmaceutical and Biotech Patent Litigation, 2005

“The Master Class on Drafting Legally Sound Opinions”, Freedom to Operate Conference, American Conference Institute, 2006

“Patent Issues Regarding Biologics and Biotechnologies”, 4th Annual Drug Patents in Canada Conference, Insight Information

“Patent and Regulatory Issues in Canada”, CLE Seminar on “Doing Business in Canada — Key Considerations for US Lawyers”, Boston Bar Association

“Practical Tips for Obtaining Funding from Canadian and US VCs and Pharma”, BioContact Quebec, 2005

“Industry/University Collaboration and Licenses”, Life Sciences IP Due Diligence — Your Complete Guide for M&As, Licensing, and Other Collaborations, American Conference Institute, 2006

“Patent Practice in the Aftermath of Festo and Vornado”, Practising Law Institute, San Francisco, CA, 2002

“When to Obtain an Outside Opinion”, Freedom to Operate Conference, American Conference Institute, 2004

“Defenses to Infringement of Research Tool Patents”, Third Advanced Forum on Biotech Patents — The Tactical and Practical Guide to Today’s Most Complex Issues, American Conference Institute, 2004

“Prosecuting the Difficult Patent Application: Affidavits and Declarations”, Annual Meeting, American Intellectual Property Law Association, 2004

“An In-House Perspective on Preparing for Patent Litigation”, Preparing Patent Legal Opinions, Practising Law Institute, 2003

Publications

“Due Diligence: Patent Landscape Review and Freedom to Operate Analysis”, Federated Press, 2011

“Patent Analysis as a Tool for Competitive Intelligence”, Federated Press, 2010

“Patents as a Competitive Strategy”, Federated Press, 2009

Bogle, G.T.; Ewart, T. Nanoparticles biosensor. U.S. Patent 5,922,537, July 13, 1997.

Professional and Community Involvement

College of Patent Agents & Trademark Agents

Licensing Executives Society

Sports Car Club of America

Porsche Club of America